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Reversible S-palmitoylation of cysteine residues
critically controls transient membrane tethering of
peripheral membrane proteins. Little is known about
how the palmitoylation machinery governs their
defined localization and function. We monitored the
spatially resolved reaction dynamics and substrate
specificity of the core mammalian palmitoylation
machinery using semisynthetic substrates. Palmitoy-
lation is detectable only on the Golgi, whereas
depalmitoylation occurs everywhere in the cell. The
reactions are not stereoselectiveand lack any primary
consensus sequence, demonstrating that substrate
specificity is not essential for de-/repalmitoylation.
Both palmitate attachment and removal require
seconds to accomplish. This reaction topography
and rapid kinetics allows the continuous redirection
of mislocalized proteins via the post-Golgi sorting
apparatus.Unidirectionalsecretionensures themain-
tenance of a proper steady-state protein distribu-
tion between the Golgi and the plasma membrane,
which are continuous with endosomes. This generic
spatially organizing system differs from conventional
receptor-mediated targeting mechanisms and effi-
ciently counteracts entropy-driven redistribution of
palmitoylated peripheral membrane proteins over all
membranes.INTRODUCTION
S-palmitoylation of cysteine residues is a common posttransla-
tional modification found on integral and peripheral membrane458 Cell 141, 458–471, April 30, 2010 ª2010 Elsevier Inc.proteins, many of which are central elements in signal transduc-
tion, synaptic function, or membrane trafficking and fusion
(Bijlmakers and Marsh, 2003; Smotrys and Linder, 2004). Palmi-
toylation can promote stable tethering of otherwise cytosolic
proteins to intracellular membranes, can contribute to altered
anterograde and endocytic trafficking of integral membrane
proteins (Charollais and Van Der Goot, 2009), and, for both,
can account for their lateral segregation into lipid microdomains
(Melkonian et al., 1999). Palmitoylation is the only reversible
lipid modification (Magee et al., 1987). Cycles of de- and reacy-
lation govern the transient membrane association of peripheral
membrane proteins and thereby regulate their steady-state
localization, sorting, and function (Greaves and Chamberlain,
2007; Huang and El-Husseini, 2005; Rocks et al., 2006).
However, the parameters and rules that determine the localiza-
tion of peripheral membrane proteins via palmitoylation and
depalmitoylation in cells are unclear. Palmitoylation activity
was assigned to several membrane compartments (El-Husseini
et al., 2002; Fishburn et al., 1999; Rocks et al., 2005; Swarthout
et al., 2005; van’t Hof and Resh, 1997), and depalmitoylation was
shown to occur at least at the plasma membrane (PM) (El-Hus-
seini et al., 2002; Rocks et al., 2005) and estimated palmitate
turnover kinetics range from 1 hr (Baker et al., 2003; Lu and
Hofmann, 1995) to a fewminutes (Rocks et al., 2005). Both enzy-
matic and nonenzymatic mechanisms of palmitoylation were
proposed. It occurs spontaneously in vitro (Ban˜o´ et al., 1998;
Quesnel and Silvius, 1994) and targets the same cysteines that
are palmitoylated in cells. Structural integrity of the substrate is
not required since palmitate is also transferred to corresponding
short peptides (Ban˜o´ et al., 1998; Bizzozero et al., 2001; Quesnel
and Silvius, 1994). Recently, protein acyltransferases (PATs)
were identified in yeast and subsequently in the human genome,
most notably the 25 members of the mammalian DHHC pro-
tein family (Mitchell et al., 2006). For individual candidate
PATs apparent substrate selectivity was reported (Linder and
Deschenes, 2007; Tsutsumi et al., 2008), but a consensus
sequence for S-palmitoylation has not yet been identified
(Bijlmakers and Marsh, 2003; Smotrys and Linder, 2004). In a
proteomic screen in yeast (Roth et al., 2006), both discrete and
overlapping functionalities among the candidate PATs were
shown. Acyl protein thioesterase 1 (APT-1) currently is the only
thioesterase activity (TE) known to depalmitoylate in vivo (Zeid-
man et al., 2009) (P.I.H.B. and H.W., unpublished data).
Here, we delineate the critical parameters that govern the
spatial organization of palmitoylated peripheral membrane
proteins. By monitoring the turnover kinetics of semi-synthetic
PAT/TE substrate proteins that we introduce into cells, we deter-
mine the localization, efficiency, and specificity of the core
mammalian palmitoylation machinery.
RESULTS
Monolipidated Substrates for S-Palmitoylation Rapidly
and Randomly Partition over All Membranes
Palmitoylated peripheral membrane proteins typically contain an
irreversibly attached prenyl or myristoyl moiety in proximity to
the palmitoylation site. We first questioned whether singly
lipidated proteins exhibit a specific membrane distribution to
facilitate their subsequent S-palmitoylation. Mutant solely farne-
sylated HRasC181,184S and solely myristoylated MyrSer (32 aa
peptide [Navarro-Le´rida et al., 2002]) that cannot get palmitoy-
lated were equipped with mCherry and mCitrine, respectively,
to observe their steady-state localization. In both cases, the
fluorescence distribution did not show a preference for any
membrane compartment, butmerely reflectedmembrane densi-
ties (Figure 1A). Photoactivatable GFP-fused versions of both
proteins rapidly redistributed over all membranes, reaching
steady-state within the first seconds after photoactivation
(Figures 1B and 1C). In order to confirm that the monolipidated
proteins also had access to the PM, TIRF microscopy was
performed on the wild-type and monolipidated mutant proteins.
As expected, the fully lipidated wild-type proteins clearly
showed an enrichment at the PM (Figure 1D). However, both
monolipidated mutants also exhibited clear PM localization, es-
tablishing that they have access to this membrane. These exper-
iments are inconsistent with the presence of receptors for mono-
lipidated proteins on specific membrane compartments (Choy
et al., 1999). Instead, proteins with only one attached lipid rapidly
and randomly sample all membranes until they are trapped
because of an increase in their affinity for membranes by the
acquisition of additional lipid anchors at the site of palmitoyla-
tion. This kinetic trapping (Shahinian and Silvius, 1995) is an
essential aspect of the spatial organization of palmitoylated
peripheral membrane proteins that can be exploited to detect
the subcellular site of palmitoylation.
Subcellular Localization and Kinetics of Ras
Palmitoylation
We prepared a set of semisynthetic NRas proteins that feature
differentially lipid-modified heptapeptides ligated to fluores-
cently labeled recombinant NRas(1–181). This was achieved by
employing a combination of solid phase lipopeptide synthesis
and peptide-protein ligation (Figure 2A, Figure S1 available
online) (Kuhn et al., 2001). After introduction of these probesinto living cells, we directly monitored their spatially resolved
palmitate turnover kinetics by making use of the phenomenon
of kinetic trapping (Shahinian and Silvius, 1995) that is apparent
from a local probe accumulation caused by a decrease in effec-
tive diffusion. We investigated the subcellular site and the
kinetics of Ras palmitoylation using CysFar, a substrate for acyl-
ation resembling depalmitoylated NRas (Figure 2A). This solely
farnesylated protein rapidly distributed over all membranes
directly after injection (Figure 2B), similar to palmitoylation-defi-
cient but farnesylated HRasC181,C184S (Figures 1A and 1C).
At the same time, stable membrane anchoring of the probe at
the site of palmitoylation was apparent as rapid accumulation
of CysFar specifically at the Golgi with a t/2 of 14 ± 8.4 s (n = 9,
Figures 2B and 2C). Only at later time points a fluorescence
increase at the PM could be observed showing that Golgi
exit of the palmitoylated probe via the secretory pathway
(Figure S2A) accounts for enrichment of palmitoylated Ras at
the PM (Choy et al., 1999). In contrast, SerFar, a probe that
cannot undergo palmitoylation, nonspecifically distributed over
endomembranes (Figures 2A, 2D, and 2E upper panel). This
was also observed for CysFar after blocking the cysteine
with N-ethylmaleimide (Figure S2B). Photobleaching of SerFar
at the Golgi resulted in rapid fluorescence recovery within
seconds, comparable to the redistribution of palmitoylation-defi-
cient HRasC181S,C184S (Figure 2E, lower panel). In contrast,
CysFar fluorescence recovery at the Golgi was 13-fold slower
(t/2 = 29 ± 6.8 s, n = 7), showing that its Golgi pool is more stably
membrane anchored as a result of palmitoylation. In cells
pretreated with 2-bromopalmitate, which inhibits palmitic acid
biosynthesis and thereby indirectly protein palmitoylation
(Webb et al., 2000), specific Golgi enrichment of CysFar was
blocked (Figure 2F). Similar rapid and specific accumulation of
CysFar on the Golgi was observed in COS7 and MCF7 cells
(data not shown). We conclude that palmitoylation of the car-
boxy-terminal prenylated substrate protein Ras occurs on the
time scale of seconds and is confined to the surface of the Golgi
apparatus.
Palmitoylation of Peripheral Membrane Proteins
at the Golgi
In order to investigate the generality of the Golgi as palmitoyla-
tion site, we asked whether the two other classes of cytosolic
palmitoylatable substrates in mammals, i.e., proteins that are
N-myristoylated and S-palmitoylated at the N terminus and
proteins that are only S-palmitoylated (Bijlmakers and Marsh,
2003), undergo similar rapid palmitoylation at the Golgi. We
tested semisynthetic Gai1Cys, an amino-terminal palmitoylat-
able substrate embodying a N-myristoylated heptapeptide
derived from the heterotrimeric G protein alpha i1 subunit, and
semisynthetic GAP43Cys, comprising the first 20 amino acids
of GAP43 including its two palmitoylatable cysteines (Figure 3A).
Gai1Cys exhibited Golgi accumulation characteristics (t/2 = 21 ±
11 s, n = 6) comparable to CysFar and became enriched at the
PM also only later after injection. Local membrane trapping
was blocked by replacement of the target cysteine with serine
or by the presence of 2-bromopalmitate (Figures 3B and 3C,
Figure S3). GAP43 lacks additional lipid anchors and might
gain access to the palmitoylation machinery by a weak intrinsicCell 141, 458–471, April 30, 2010 ª2010 Elsevier Inc. 459
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Figure 1. Rapid and Random Partitioning of Monolipidated Proteins
(A) Steady-state localization of MyrSer is similar to that of HRasC181S,C184S.
(B and C) Fluorescence loss of photoactivated MyrSer-paGFP (B) and paGFP-HRasC181S,C184S (C) at the perinuclear region in MCDK cells, showing that
both single lipidated proteins rapidly and indiscriminately sample different cellular membrane systems with comparable membrane residence times. PA,
photoactivation.
(D) Total internal reflection fluorescence (TIRF) images of MDCK cells expressing Citrine-HRras or Citrine-HRasC181S,C184S and MyrSer-Citrine. The fluores-
cence signals from the lipidated proteins were normalized to soluble mCherry to show the disparity in contrast reflecting their PM localization. Free mCitrine/
mCherry images are shown as controls, showing disparity arising due to differences in optical parameters of the TIRF field.
Scale bars represent 10 mM. Color bar indicates normalized range of pixel ratios from minimum (blue) to maximum (red).
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Figure 2. Ras Palmitoylation Is Fast and Restricted to the Golgi
(A) Schematic illustration of the Cy3-labeled semisynthetic lipoproteins. Different lipopetide-heptamers were coupled via a maleimidocaproyl linker to recombi-
nant NRas (1–181).
(B) Confocal time-lapse images of MDCK cells transiently expressing the Golgi marker GalT-CFP and Citrine-NRas prior and after microinjecton of CysFar.
(C) Quantitative ratiometric analysis of CysFar accumulation at the Golgi (black, n = 9) and the PM (red, n = 4) with local Citrine-NRas intensity used as reference.
Plateau fluorescence ratios at the Golgi were normalized to one.
(D) Time-lapse images of MDCK cells microinjected with nonpalmitoylatable SerFar.
(E) Top: contrast of SerFar fluorescence at the Golgi over adjacent membranes and cytosol (red, n = 4) compared to CysFar (black, n = 9). Bottom: fluorescence
recovery after selective photobleaching of SerFar (red, n = 5) or CysFar (black, n = 7) at theGolgi 5min after microinjection. The recovery of local fluorescence was
ratiometrically quantified with Citrine-NRas used as a Golgi reference. Results were compared to Golgi photobleaching data of Citrine-HRasC181,184S (yellow,
n = 3) in cells coexpressing CFP-NRas as a Golgi reference. Plateau values were normalized to one.
(F) Microinjection of CysFar in MDCK cells preincubated with 50 mM 2-bromopalmitate for 45 min.
All scale bars represent 10 mm. See also Figures S1 and S2.membrane affinity (El-Husseini et al., 2000; Greaves et al.,
2009). GAP43Cys, but not a serine double mutant, accumulated
specifically on the Golgi but not on any other cellular membrane
(t/2 = 29 ± 15 s, n = 7, Figures 3C and 3D, Figure S4A), similar to
CysFar.We also studied a probe comprising the amino-terminal
N-myristoylated heptapeptide of the Fyn kinase that was
previously shown to be palmitoylated at the PM (van’t Hof
and Resh, 1997). FynCys, but not a serine double mutant,
accumulated initially only at the Golgi (t/2 = 16 ± 4.2 s, n = 5,Cell 141, 458–471, April 30, 2010 ª2010 Elsevier Inc. 461
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Figure 3. Rapid palmitoylation of different classes of substrates on the Golgi
(A) Schematic illustration of the peptide portions of Gai1Cys (featuring a palmitoylatable N-myristoylated heptapeptide derived from the amino-terminus of Gai1)
and of GAP43Cys (featuring the first 20 amino acids of GAP43, including two palmitoylatable cysteines) mounted to Cy3-labeled recombinant NRas (1–181) and
of FynCys (featuring a doubly palmitoylatable N-myristoylated heptapetide derived from the amino-terminus of Fyn kinase) mounted to recombinant GFP.
(B) Confocal time-lapse images ofMDCK cells microinjected with Gai1Cys transiently expressing both the Golgi marker GalT-CFP andCitrine fused to the first ten
amino acids of Gai1.
(C) Top: quantitative ratiometric analysis of Gai1Cys accumulation at the Golgi (n = 6) and contrast of Gai1Ser fluorescence at theGolgi over adjacent membranes
and cytosol (red, n = 4) compared to Gai1Cys (black, n = 6). Bottom: quantitative ratiometric analysis of FynCysGFP accumulation at the Golgi (black n = 5) and at
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Figure 4. Rapid Depalmitoylation on All
Membranes
(A) Left: confocal time-lapse images of MDCK
cells expressing Citrine-NRas microinjected with
PalFar. Top right: quantitative analysis of PalFar
accumulation at the Golgi (black, n = 7) and the
PM (red, n = 5) with local Citrine-NRas intensity
used as reference. Bottom right: comparison of
Golgi accumulation kinetics of microinjected
PalFar (black, n = 7) and CysFar (red, n = 9).
(B) Contrast of PalFar fluorescence at the Golgi
over adjacent membranes and cytosol (black,
n = 7) compared to HDFar (red, n = 3).
(C) Confocal time-lapse images of MDCK cells
expressing Citrine-NRas microinjected with non-
depalmitoylatable HDFar.
(D) Fluorescence recovery after selective photo-
bleaching of PalFar at the Golgi (black, n = 5)
compared to CysFar (red, n = 7) shortly after
microinjection. Recovery was ratiometrically
quantified with local Citrine-NRas fluorescence
intensity used as reference.
All scale bars represent 10 mm. See also Figure S5.Figures 3A, 3C, and 3E, Figure S4B) but not at the PM. Only at
later time points enrichment of the probe at the PM occurred
due to anterograde transport of palmitoylated probe via the
secretory pathway (t/2 = 173 ± 64 s, n = 5). Interestingly, the
PM localization of FynCys at steady state was more pronounced
than that for the other probes. The longer membrane residence
time of this probe indicates lower palmitate turnover kinetics,
similar to those that can be imposed on HRas by increasing
the number of palmitoylated cysteine residues throughmutagen-
esis (Figure 3C; see below). This explains why genetically
expressed full-length Fyn or Fyn(1–11) mostly localize at the PM.
As expected, but contrary to a recent study (Sato et al., 2009),
temperature block of anterograde vesicular transport shifts the
steady-state distribution of Fyn back toward the Golgi (Fig-
ure 3F). Various other palmitoylated peripheral membrane
proteins do not exhibit clear Golgi localization, implying that they
are palmitoylated on other membrane systems. Prenylated and
palmitoylated RhoB, TC10, RRas, and Rap2C typically decorate
the endocytic and/or lysosomal compartment along with the PM
(Kawase et al., 2006; Paganini et al., 2006; Pe´rez-Sala et al.,the PM (n = 5, red), using local Gai1(1–10)-Cherry intensity as reference. Plateau values were normalized to o
accumulation at the Golgi (n = 7).
(D) Confocal time-lapse images of MDCK cells microinjected with GAP43Cys expressing both the Golgi marke
additional lipid anchors allows for nuclear diffusion of unprocessed probe.
(E) Time-lapse images of MDCK cells microinjected with FynCys-GFP expressing Gai1-Cherry.
(F) Vesicular transport block at 16C (1 hr incubation) shifts the steady state distribution of WT Fyn to the G
(G) Confocal images of the steady-state localization of various prenylated and palmitoylated proteins in fixed
16C for 10 hr.
All scale bars represent 10 mm. See also Figures S3, S4, and S6.
Cell 141, 458–42009; Takaya et al., 2007). We tested
whether palmitoylation of these proteins
nevertheless occurs on the Golgi. Indeed,
a temperature block of vesicular transport
resulted in a robust shift of their steady-state localization to the Golgi (Figure 3G). This also shows that
these proteins exhibit a slower palmitate turnover, which allows
them to reach the endocytic compartment via the PM. The above
experiments with representative substrates of all three classes
of peripheral membrane proteins, together with the data shown
in Figure 2, demonstrate that the surface of the Golgi is the
predominant subcellular site of peripheral membrane protein
palmitoylation in mammalian cells. It provides directionality to
the acylation cycle by making use of the secretory functionality
of the Golgi that targets the PM.
Homogeneous Protein Depalmitoylation
We then studied palmitate removal in cells in order to understand
how the overall palmitoylation machinery controls protein
localization. First, we analyzed the depalmitoylation kinetics
of PalFar, a substrate for palmitate removal resembling fully
lipid modified NRas (Figure 2A). PalFar rapidly accumulated
on the Golgi shortly after microinjection (Figures 4A and 4B,
Figure S5A) with a t/2 of 27 ± 8.6 s (n = 7), which is onlymarginally
slower than CysFar. This probe is expected to insert into allne. Quantitative ratiometric analysis of GAP43Cys
r GalT-CFP and Citrine-NRas. Note that the lack of
olgi apparatus in MDCK cells.
MDCK cells at 37C or after temperature block at
71, April 30, 2010 ª2010 Elsevier Inc. 463
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Figure 5. Depalmitoylation Is a Fully Distrib-
uted Process
(A) Time-lapse images of MDCK cells expressing
Gai1(1–10) fused to paGFP and Gai1(1–10) fused
to mCherry. paGFP was selectively photoacti-
vated at the Golgi by short illumination with
405 nm laser light. Images were taken before and
after photoconversion at the indicated time points.
The scale bar represents 10 mm. For information
on palmitoylation kinetics of an injected Gai-hep-
tapeptide GFP fusion probe, see Figure S6.
(B) Ratiometrically determined decrease of paGFP
fluorescence at the Golgi after photoconversion of
the palmitoylated fusion proteins HRas (n = 6),
NRas (n = 9), Gai1(1–10) (n = 8) and HRasC181S
(n = 9), or of solely farnesylated HRasC181,184S
(n = 5). Peak values were normalized to one. An
overlay of all curves is displayed in the lower-right
graph.
(C) Ratiometrically determined decrease of
paGFP-HRasC181S fluorescence at the Golgi
after photoconversion in presence or absence of
1 mM palmostatin B for 45 min, compared to
paGFP-HRas in untreated cells.
(D) Confocal images of MDCK cells expressing
Citrine-HRas179C183C containing four potential
palmitoylation sites together with wild-type CFP-
HRas (upper panel) or GalT-CFP (lower panel).
Scale bars represent 25 mm.cellular membranes after microinjection, where it remains stably
tethered: a situation reflected by the nonspecific membrane
localization of a PalFar analog that cannot undergo de-/repalmi-
toylation because of a noncleavable thioether bond (HDFar,
Figures 2A, 4B, and 4C). This shows that depalmitoylation effi-
ciently releases PalFar from all membranes before rapid diffusion
and repalmitoylation results in its membrane trapping on the
Golgi. PalFar also appeared at the PM a few minutes after in-
jection as a result of anterograde transport of probe that had
been repalmitoylated on the Golgi (Figure 4A, Figures S5A and
S5B). Photobleaching recovery kinetics of PalFar at the Golgi
were similar to CysFar (Figure 4D), confirming that PalFar was
indeed depalmitoylated when reaching the Golgi, thereby
showing that the injected probe is accessible for palmitate
removal everywhere in the cell. 2-bromopalmitate treatment464 Cell 141, 458–471, April 30, 2010 ª2010 Elsevier Inc.)
,
f
tinhibited specific Golgi accumulation of
PalFar (Figure S5C). These experiments
demonstrate that both palmitoylation
and depalmitoylation in cells occur within
seconds and are thus at least two orders
of magnitude faster than previously
concluded from pulse-chase experi-
ments (Baker et al., 2003; Linder and De-
schenes, 2007; Lu and Hofmann, 1995).
In a complementary approach, we
assessed whether depalmitoylation
occurs as early in the acylation cycle as
at the Golgi, thereby showing that it is
a fully distributed process. For this, palmi-
toylatable constructs with different palmi-tate turnover rates (Lu and Hofmann, 1995; Rocks et al., 2005
fused to photoactivatable GFP were expressed. The probes
were selectively photoactivated on the Golgi and the decrease
in local fluorescence was followed over time (Figures 5A and
5B). Because we are photoactivating material at the Golgi
the relative decrease of local fluorescence is only affected by
the clearance rate constant (kc). The observed residence time
(t/2 = 1/kc) will be the inverse of the sum of the rate constant o
clearance by the secretory pathway and the rate constan
of clearance by depalmitoylation and subsequent diffusive
loss. If there is no depalmitoylation at the Golgi, the observed
residence time will only depend on the secretory pathway and
should therefore be the same for all tested palmitoylated mole-
cules. However, a clear correlation was found between the
residence time of these proteins on the Golgi and their kinetics
of palmitate turnover (see Figure S6): fluorescence decay of
double palmitoylated and farnesylated paGFP-HRas was
slowest (t/2: 157 ± 13 s, n = 6), followed by monopalmitoylated
and myristoylated paGFP-Gai1 (aa 1–11; t/2: 140 ± 19 s, n = 8)
and monopalmitoylated and farnesylated paGFP-NRas (t/2:
121 ± 22 s, n = 9), while the fastest fluorescence decay was
observed for monopalmitoylated and farnesylated paGFP-
HRasC181S (t/2: 60 ± 10 s, n = 9). As a control, nonpalmitoylat-
able paGFP-HRasC181,184S rapidly decayed within a few
seconds. Importantly, the rate constants of Golgi clearance for
themonopalmitoylated C181Smutant and double-palmitoylated
wild-type HRas converged in presence of palmostatin B, an
inhibitor of depalmitoylation (P.I.H.B. and H.W., unpublished
data), demonstrating that the differently palmitoylated probes
are indeed indiscriminately sorted into Golgi exit vesicles (Fig-
ure 5C). The correlation between the kinetics of palmitate
removal and Golgi residence time clearly shows that palmitate
removal already takes place at the Golgi. In fact, the depletion
of paGFP-HRasC181S from the Golgi is more than one order of
magnitude faster than the reported time scale of vesicle release
into the secretory pathway (Hirschberg et al., 1998). Palmitate
removal on the secretory pathway/Golgi prevents a substantial
fraction of palmitoylated proteins from reaching the PM, since
it redirects these proteins into the acylation cycle before they
can reach the PM via the secretory pathway. This short circuit
in the transport cycle affects the relative steady state PM/Golgi
partitioning of a palmitoylated protein and causes a stronger
uncoupling of the endomembrane protein pool from the PM
compartment. Indeed, incorporation of two additional palmitoy-
lation sites to the HRas carboxy-terminus (HRas179C,183C)
results in a more pronounced steady-state PM localization
(Figure 5D), as expected for a protein with slower apparent
palmitate turnover kinetics.
Substrate Specificity of the Core Palmitoylation
Machinery
We have shown that the spatial organization of palmitoylated
peripheral membrane proteins is controlled by the topographic
organization of the de-/reacylation machinery and its high proc-
essivity. We then investigated whether the resulting specificity in
localization is achieved by a generic—i.e., nonspecific–overall
palmitoylation mechanism. Proteins are chiral catalysts and their
selectivity to a major extent is based on recognizing the chirality
of their substrates. We therefore conversed CysFar and PalFar
into their stereoisomeric counterparts with amino acid configura-
tion altered in the immediate vicinity of the palmitoylation site as
an utmost test of the stereotolerance of both lipidation and deli-
pidation. D-CysFar and D-PalFar are semisynthetic proteins that
resemble CysFar and PalFar in their side-chain functionality but
feature the last seven carboxy-terminal amino acids in nonnat-
uralD-configuration (Figure 6A). Thereby, secondary recognition
sites in the palmitoylation and depalmitoylation reaction in
vicinity to the target cysteine are likely to be disrupted. However,
both D-CysFar and D-PalFar rapidly accumulated on the Golgi,
with kinetics indistinguishable from their L-configured counter-
parts (Figures 6B and 6C). This demonstrates that the core
cellular palmitoylation and depalmitoylation machinery is not
stereoselective. We asked whether palmitate transfer or removalrequires any form of molecular recognition at all of structural
patterns in vicinity to the target cysteine. Semisynthetic b-Cy-
sFar and b-PalFar feature heptapeptides made of b amino acids
that contain an additional carbon atom between the amino and
carboxy groups (Figure 6A) (Seebach et al., 2004). These modi-
fications do not affect the integrity of the side chains but at most
alter the secondary structure of the carboxy-terminus of the
probe, including the target cysteine itself. Moreover, the
b peptide backbone is one-third longer than the natural counter-
part heptapeptide. Both microinjected b-CysFar and b-PalFar
were rapidly trapped on the Golgi by palmitoylation with kinetics
similar to CysFar or PalFar, respectively (Figures 6D and 6E). We
therefore conclude that no consensus sequence is involved in
cellular palmitoylation and that there is no essential requirement
for the de-/repalmitoylation machinery to recognize any struc-
ture on the substrate other than the target cysteine side chain.
The above experiments also confirm the central role of the Golgi
in cellular palmitoylation and thereby reveal the generic nature of
the spatially organizing system that is constituted by the two lipid
modifying activities. The specific Golgi accumulation of all
probes was blocked in the presence of 2-bromopalmitate (data
not shown).
We investigated the involvement of offsite recognition in pal-
mitoyl turnover of our probes via putative motifs on the Ras-G-
domain distal to the target cysteine. First, YFP-tH, a YFP fusion
of the minimal C-terminal membrane targeting sequence of
HRas (aa 175–190) and full-length mCherry-HRas exhibited an
identical steady-state partitioning over the PM and the Golgi
(Figure 7A). They therefore must have identical palmitoyl turn-
over kinetics arguing against recognition of the Ras G-domain
by the palmitoylationmachinery. Second,Gai1Cys-GFP, a probe
where the amino-terminal Gai1 heptapeptide is coupled to GFP
instead of truncated NRas, displayed kinetics of Golgi accumu-
lation similar to Gai1Cys (t/2 = 18 ± 5 s, n = 5), showing that the
NRas protein core is dispensable for the recognition of the hep-
tapeptide substrate by the palmitoylation machinery (Figure S6;
see also Figures 3C and 3E). Finally, we investigatedwhether any
specificity for the palmitoylation reaction resided in the DHHC
domain-containing proteins. Previous studies have suggested
that the DHHC PATs have distinct, albeit overlapping, specific-
ities (Linder and Deschenes, 2007; Roth et al., 2006; Tsutsumi
et al., 2008). Human DHHC9 and Yeast Erf2 have so far been
identified as RasPATs on the basis of biochemical assays
(Lobo et al., 2002; Swarthout et al., 2005), and evidence also
exists for DHHC17 and 18 (Fukata et al., 2004; Huang et al.,
2004). However, short hairpin RNA (shRNA)-mediated knock-
down of DHHC9 showed no detectable effect on Ras palmitoy-
lation, as evident from a steady steady-state localization and
recovery kinetics of HRas photobleached at the Golgi that are
similar to control cells (Figures 7B–7D). We therefore used
a Hidden Markov Model (HMM)-based bioinformatics approach
(Smyth, 1997) to classify the 25 human DHHC proteins into
different classes on the basis of biochemical data indicating
their preferred protein substrates (Extended Experimental
Procedures). Indeed, the HMM indicated closer relationships
(Figure S7A) between these particular DHHC proteins with the
consensus sequence ‘‘W-X(4)-L-X(12)-TTNE’’ in mammalian
and yeast proteins (Figure S7B) that was correlated with RasPATCell 141, 458–471, April 30, 2010 ª2010 Elsevier Inc. 465
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Figure 6. Substrate Tolerance of the Palmitoylation Machinery
(A) Schematic illustration of the heptapeptide portions of semisynthetic D-CysFar and b-CysFar.
(B) Confocal time-lapse images after microinjection of D-CysFar (left) and D-PalFar (right) in MDCK cells expressing Citrine-NRas.
(C) Ratiometric analysis ofD-CysFar (left, n = 6) andD-PalFar accumulation at the Golgi (center, n = 6) with local Citrine-NRas used as a reference. Right: compar-
ison of both.
(D) Microinjection of b-CysFar (left) and b-PalFar (right) in MDCK cells expressing Citrine-NRas.
(E) Ratiometric analysis of b-CysFar (left, n = 4) and b-PalFar accumulation at the Golgi (center, n = 7) and comparison of both (right).
All scale bars represent 10 mm.activity as described by previous biochemical assays. Scanning
of multiple genomes with this consensus sequence revealed that
the Dictyostelium genome contained only homologs of human466 Cell 141, 458–471, April 30, 2010 ª2010 Elsevier Inc.DHHCs 1–8, and while this organism has at least 11 Ras iso-
forms, none have a palmitoylatable cysteine. Therefore, if indeed
Ras specific PAT activity exists, human HRas should not
become palmitoylated when expressed in Dictyostelium discoi-
deum.HumanHRaswas however palmitoylated inDictyostelium
cells as indicated by its clear enrichment at the PM and certain
internal membranes including endosomes (Figure 7E). The latter
organelle that originates from the PM is abundantly present in
Dictyostelium cells (Gerisch et al., 2004). The enrichment of
HRas on the PM and endosomes was lost upon inhibiting palmi-
toylationwith 2-bromopalmitate, similar to the effect onmamma-
lian cells (Figure S3). FRAP kinetics showed that the relatively
slow motility of HRas in Dictyostelium cells (Figure 7F) was
consistent with that of palmitoylated HRas (t1/2 = 183.3 ± 3.8 s)
as observed in mammalian cells (Figure 2E). These experiments
show that no specific PAT activity exists for Ras and confirm the
substrate tolerance of the palmitoylation machinery.
DISCUSSION
In this study, we applied a chemical-biological approach to
directly monitor dynamic palmitoylation in single cells. We un-
covered the subcellular topography and the reaction dynamics
of the core palmitoylationmachinery inmammalian cells, thereby
revealing a generic spatially organizing system that controls the
subcellular localization of peripheral membrane proteins. Bulk
palmitoylation occurs on the Golgi. This organelle provides
directionality in the acylation cycle by allowing locally palmitoy-
lated proteins to enter the secretory pathway from where
they are targeted to the PM. Even these polylipidated proteins
will eventually redistribute to all cellular membranes to reach
equilibrium. This is countered by rapid and ubiquitous depalmi-
toylation that causes an increase in the effective diffusion of
depalmitoylated proteins, and therebymediates their continuous
redirection to the Golgi from any given cellular membrane
by local kinetic trapping. Remarkably, this de-/repalmitoylation
machinery constitutes a spatially organizing system that does
not require any form of direct ligand/receptor interaction in order
to spatially segregate proteins. It dynamically maintains their
spatial organization out of equilibrium by generating a directional
flow from the Golgi to the PM. This counteracts the tendency of
the system to increase its entropy by protein redistribution over
all membranes. This directed transport acts like a conveyor belt
along which palmitoylated peripheral membrane proteins are
continuously enriched. The steady-state partitioning between
Golgi and the PM with its interconnected endocytic compart-
ment is dictated by the kinetics of palmitate turnover (Rocks
et al., 2005) (Figures 5D, 3F, and 3G). Additional sorting signals
or protein interactions could allow the palmitoylated proteins to
access more specialized membrane subcompartments as for
instance in neuronal cells (Huang and El-Husseini, 2005; Jura
et al., 2006; Kang et al., 2008).
Numerous publications over the last few years have estab-
lished the role of DHHC family proteins in protein palmitoylation
in yeast and mammals. As anticipated for a typical enzyme,
substrate specificity has been described for several of the
DHHC proteins (Huang et al., 2009; Linder and Deschenes,
2007; Tsutsumi et al., 2008). These findings are mostly based
on changes in the palmitoylation level of a putative substrate
protein observed upon co-overexpression of DHHC proteins.
Our study challenges the assumption that specific individualPAT/substrate pairs are prerequisite in palmitate transfer. The
experiments with D amino acids and nonnatural peptides clearly
demonstrate that the sequence context flanking the target
cysteine on the substrate does not contribute to substrate recog-
nition. A recent study in yeast further supports the assumption of
overlapping specificities (Hou et al., 2009).We thus propose that,
inmammalian cells, any protein is qualified for palmitoylation that
contains a surface-exposed and freely accessible cysteine that
has transient access to Golgi membranes. This transient Golgi
membrane proximity can be accomplished by nearby myristoyl
or prenyl lipid anchors or nearby transmembrane domains, by
binding to other proteins that permit transient Golgi accessibility
or by an intrinsic weak membrane affinity.
No matter what type of substrate protein we tested—repre-
sentatives of the three types of peripheral membrane proteins
or, most importantly, probes with D amino acid configuration
or nonnatural peptides—we always observed rapid palmitoyla-
tion only on the surface of the Golgi. This highly efficient core
palmitoylation machinery rapidly processes any available target
protein with very wide substrate tolerance. Palmitoylation activ-
ities on other subcellular sites such as the PM are feasible but
would be relevant only for palmitoylatable proteins that do not
have repeated access to the Golgi, like transmembrane proteins.
Since our probes did not detect such activities, putative non-
Golgi PATs must be far less efficient than the Golgi palmitoyla-
tion machinery or might involve additional specific offsite recog-
nition that would prevent immediate turnover on the Golgi
(discussed below). However, unlike in yeast, where PATs have
been found on various different endomembrane systems (Hou
et al., 2009; Ohno et al., 2006), all DHHC proteins in humans
so far shown to be of enzymatic relevance localize at the Golgi
(Ferna´ndez-Hernando et al., 2006; Huang et al., 2009; Ohno
et al., 2006), with the exception of neuronal DHHC2 (Noritake
et al., 2009).
Why are there 25 DHHC proteins in mammals? In our study
we could rule out off-site recognition as an essential feature in
the cellular palmitoylation reaction and, specifically, its involve-
ment in the palmitoylation of Ras and of small palmitoylatable
peptides. However, it might contribute to the efficiency of palmi-
toylation. There are no obviousmotifs for such recognition on the
DHHC proteins distal to their active site and/or the substrates
distal to the target cysteine. Only three of the 25 DHHC family
members contain protein interaction domains (SH3 on DHHC6
and ankyrin repeats on DHHC13 and 17), with DHHC5/8 and
DHHC14 encoding potential PDZ binding motifs (type II and
type I, respectively). Therefore, distal interaction would likely
involve electrostatic or hydrophobic affinity but not structural
recognition. Whether this is generally relevant or only applies
to special cases such as the recently shown interaction between
the yeast vacuole PAT Pfa3 and its substrate Vac8 (Hou et al.,
2009; Nadolski and Linder, 2009) remains to be investigated. It
is also noteworthy that at least some DHHC proteins might
have biological functions independent of their PAT activity as
has been shown recently for the yeast DHHC protein Swf1p in
polarized secretion (Dighe and Kozminski, 2008).
Wide substrate tolerance is a known phenomenon in organic
synthesis exploiting acylating and deacylating enzymes (Drauz
and Waldmann, 2002). Therefore, a nonclassical enzymaticCell 141, 458–471, April 30, 2010 ª2010 Elsevier Inc. 467
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Figure 7. HRas Does Not Require Distal Recognition or Specific PATs for Correct Localization
(A) Comparison between the localization of full length HRas fused to mCherry and the C terminus of HRas fused to YFP. Equivalent distribution of the fragment
versus full-length protein has a theoretical value of 1. Quantification of the experiment shows complete equivalence of both constructs (value of 1.02 ± 0.04).
(B) Lentiviral shRNA-mediated downregulation of DHHC9 expressions in HeLa cells analyzed by quantitative RT-PCR with Actin B RNA used as reference. Error
bars represent standard error of mean of percentages calculated from D(DCt) values in three independent runs.
(C) Steady-state localization of HRas in DHHC9 knockdown and control HeLa cells.
(D) Fluorescence recovery after photobleaching of HRas at the Golgi in DHHC9 knockdown (n = 7) and control (n = 4) cells. The recovery of local fluorescencewas
ratiometrically quantified with GalT-CFP used as a Golgi reference. Plateau values were normalized to one.
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mechanism of palmitoylation is conceivable where DHHC pro-
teins participate in a Golgi-based machinery that coordinates
the accumulation, storage, relay and presentation of palmitoyl-
CoA and accomplishes the bulk cellular palmitate transfer.
DHHC proteins have been shown to be autoacylated (Lobo
et al., 2002) and may establish a continuously preformed set of
thioester-charged intermediates with high acylation potential.
Once the acylated DHHC-protein encounters a substrate thiol,
the thioesters are exchanged and the reaction would be driven
by lateral diffusion and vesicular export of the product.
Do dynamic changes in palmitate turnover rates, as observed
upon extracellular stimulation (El-Husseini et al., 2002; Kang
et al., 2008), occur directly at the level of the PATs/thioesterase
activity (Tsutsumi et al., 2008)? The fast kinetics and the lack
of primary substrate specificity of the palmitoylation machinery
as revealed in this study do not support this notion. However,
regulation of palmitate turnover rates by extrinsic cues can very
well arise indirectly from changes in the accessibility of thiol or
thioester groups on the substrate protein, for example upon
conformational changes of the substrate or upon masking or
unmasking by other proteins. Likewise conceivable, stimulus-
induced remodeling of the secretory pathway could alter the
transport kinetics of palmitoylated proteins cycling between the
Golgi andperipheralmembranes. Suchchanges in substrate flow
rates that will ultimately translate into altered apparent palmitate
turnover rates might particularly be critical for palmitoylated
proteins trafficking between Golgi outposts and dendritic spines
in neuronal cells (Horton and Ehlers, 2003; Kang et al., 2008).
Our findings are relevant for drug discovery programs aimed at
interference with aberrant signaling of palmitoylated proteins
such as oncogenic Ras. Chemical compounds can now be iden-
tified that interfere with the palmitoylationmachinery and thereby
modulate oncogenic Ras signaling activity by affecting its spatial
distribution (P.I.H.B. and H.W., unpublished data). Strategies to
interfere with protein palmitoylation need to however consider
the broad substrate tolerance in the palmitoylation reaction as
delineated here.
EXPERIMENTAL PROCEDURES
Generation of Synthetic Lipoproteins
Lipopeptides synthesized on solid phase were purified, and their integrity was
verified by liquid chromatography-mass spectrometry, MALDI-TOF, and
proton nuclear magnetic resonance. Purification of relevant proteins and
eGFP-Cys (eGFP with an additional C-terminal cysteine suiteable for the
MIC ligation), subsequent MIC coupling to the lipopeptides, and quality anal-
ysis by MALDI-TOF and SDS page was performed as described elsewhere
(Bader et al., 2000) (for details, see the Extended Experimental Procedures).
The NRas (1–181) protein was labeled prior to coupling with Cy3 monoreactive
dye pack (Amersham Biosciences).
Plasmid Constructs
Human HRas, NRas and mutants thereof, the MyrSer peptide, Fyn, GAP43,
Galpha(1–10), RhoB, RRas, and TC10 were fused with fluorescent proteins(E) Representative images of Dictyostelium cells (1 of 20 each) expressing HRas a
upon treatment with 2-bromopalmitate.
(F) FRAP sequences of HRas and HRasC181S,C184S with representative exam
indicating its palmitoylated state.
Scale bars represent 5 mm. See also Figure S7.into mammalian expression vectors using conventional cloning techniques.
Site-directed mutagenesis provided Cys to Ser mutant formswhen necessary.
For a detailed description of plasmid construction, see the Extended Experi-
mental Procedures.
Microscopy and Data Analysis
Confocal micrographs of various proteins and injected substrates were
corrected for background, endomembrane cytosol volume filling factors,
and segmented usingmasks for the relevant cellular compartments. Maximum
intensities on these cellular compartments were normalized to one where
appropriate and ratiometric traces were plotted against time where mentioned
(for details, see the Extended Experimental Procedures).
Cell Culture, Cell Transfection and 2-Bromopalmitate Treatment
MDCK cells were maintained in minimum essential medium supplemented
with 10% fetal bovine serum (FBS), HeLa cells in Dulbecco’s modified Eagle’s
medium (DMEM) with 10% FBS. Transient plasmid expression of MDCK cells
was achieved by overnight transfection with Effectene (QIAGEN). HeLa cells
were transfected with Fugene6 (Roche) for 6 hr and imaged 12 hr after
transfection. For live cell microscopy, cells were cultured on 35 mm glass
bottom dishes (MatTek, Ashland, MA). Transfected cells were serum starved
for 5–6 hr in 1%FBSbefore all experiments and transferred to low-bicarbonate
DMEM without phenol red supplemented with 25 mM HEPES (pH 7.4) for
microscopy. 2-bromopalmitate (50 mM) was prediluted 1:100 before addition
to the imaging medium.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and three tables and can be found with this article online at doi:
10.1016/j.cell.2010.04.007.
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